Related Experiment Video
Updated: May 3, 2026

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
Management of multivessel coronary artery disease
P B Parikh1, A J Kirtane, J W Moses
1Division of Cardiology, Department of Medicine Columbia University Medical Center/New YorkPresbyterian Hospital, New York, NY, USA - jm2456@columbia.edu.
Insights
Optimal management of multivessel disease (MVD) requires individualized treatment plans. Decisions involve percutaneous coronary intervention, bypass surgery, or medical therapy, guided by patient factors and disease severity.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiovascular Medicine
Background:
- Multivessel disease (MVD) management is complex, impacting patient prognosis.
- Clinical and angiographic scores aid treatment decisions but individualization is key.
- Choosing between revascularization (PCI/CABG) and guideline-directed medical therapy (GDMT) is critical.
Purpose of the Study:
- To review optimal management strategies for multivessel coronary artery disease.
- To discuss factors influencing the choice between revascularization and medical therapy.
- To explore various aspects of MVD treatment, including revascularization extent and guidance strategies.
Main Methods:
- Review of current literature and clinical guidelines on MVD management.
- Analysis of patient-specific factors influencing treatment decisions.
- Discussion of comparative outcomes for different revascularization strategies.
Main Results:
- Individualized patient assessment is paramount in MVD management.
- Treatment selection (PCI, CABG, GDMT) depends on clinical presentation, disease severity, and patient preference.
- Strategies include complete vs. incomplete revascularization and angiography- vs. ischemia-guided approaches.
Conclusions:
- Optimal MVD management necessitates a personalized approach integrating clinical, angiographic, and patient factors.
- The choice of revascularization modality and extent significantly influences outcomes.
- Guideline-directed medical therapy remains a crucial component, especially when revascularization is not indicated or feasible.
Abstract:
Optimal management of multivessel disease (MVD) is a complex medical decision with significant prognostic implications. Despite the advent of clinical and angiographic scores to aid with treatment delineation, therapy for MVD must be individualized for each patient and his/her clinical presentation. Particularly among patients with MVD, the selection of coronary revascularization with percutaneous coronary intervention versus coronary artery bypass graft surgery versus guideline-directed medical therapy (GDMT) alone is a prognostically important decision. Several patient factors including clinical presentation, severity of coronary artery disease, presence of left ventricular dysfunction and other comorbidities, and the patient's personal preferences should guide the decision making process. In this review, we discuss the management of MVD with regards to decisions of revascularization versus GDMT alone, mode of revascularization, extent of revascularization (i.e., complete versus incomplete), the strategy of angiography- versus ischemia-guided revascularization, and MVD management in the setting of an acute coronary syndrome.
More Related Videos
13:10Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
Published on: April 24, 2017
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis III: Management
Angina IV: Management
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis IV: Nursing Management